Generic Medicine Info
Indications and Dosage
Gastritis, Peptic ulcer
Adult: 100 mg tid.
Description: Troxipide has cytoprotective properties on the gastric mucosa. It has been postulated that troxipide's mucosal protective effect in gastric ulcer and gastritis is exerted via the inhibition of inflammatory responses and neutrophil-mediated mucosal injury. As neutrophils are thought to be involved in the pathogenesis of H. pylori-mediated mucosal injury, it is plausible that troxipide may also be able to mediate gastric mucosal damage due to H. pylori.
MIMS Class
Antacids, Antireflux Agents & Antiulcerants
Disclaimer: This information is independently developed by MIMS based on Troxipide from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2022 MIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in